Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03031626Phase 4Completed
Phase 4, randomised trial of oxygen in central sleep apnea (CSA) (2 arms), sponsored by SickKids. Primary endpoints: Change in Central Apnea-Hypopnea Index 1, Change in Central Apnea-Hypopnea Index 2 and 1 more. Started Sep 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03031626.